3
Announcements
Trials
Browse
Landscape
Status
Enrolling by invitation
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
3
Triple Negative Breast Neoplasms
1
Prostatic Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Fatigue
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Therapeutics
8
Surveys and Questionnaires
6
Psychiatric Rehabilitation
3
Mental Status and Dementia Tests
3
Interviews as Topic
2
Gene Expression Profiling
2
Enzyme-Linked Immunosorbent Assay
2
Drug Therapy
2
Amplified Fragment Length Polymorphism Analysis
2
radium Ra 223 dichloride
1
pegfilgrastim
1
enzalutamide
1
darolutamide
1
apalutamide
1
Zoledronic Acid
1
Trastuzumab
1
Reverse Transcriptase Polymerase Chain Reaction
1
Radium-223
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiosurgery
1
Radiation
1
Polymerase Chain Reaction
1
Palliative Care
1
Neuropsychological Tests
1
Microarray Analysis
1
Metformin
1
Mass Spectrometry
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Fatigue
×
Zoledronic Acid
×
Clear all
NCT04488614
2020-07-30
PBCB
Helse Stavanger HF
Enrolling by invitation
1,200 enrolled